The First Doping Case At The Paris Olympics Appears, Iraqi Guidelines Distribution

2024 Paris Olympics (ANTARA)

JAKARTA - The International Testing Agency (ITA) found the first doping case occurred at the 2024 Paris Olympics. A male fighter from Iraq tested positive for an anabolic steroid that athletes were barred from using.

ItA, which manages the independent anti-doping program for the Paris Olympics, said samples taken from an Iraqi fighter named Sajjad Sehen had "resulted in adverse analytical findings related to the banned substances metandienone and boldenone".

Quoted from ANTARA, the two drugs were banned by the World Anti-Doping Agency, the AFP reported on Saturday WIB. The sample was collected by ITA during an anti-doping examination outside the competition on Tuesday, July 23 in Paris, then the results were reported to the Paris laboratory which was accredited by WADA on Thursday, July 25.

The 28-year-old Olympic athlete, who took part in the Olympics for the first time, was supposed to compete next week in the men's 81 kilograms class.

The ITA statement said the athlete had been suspended until the matter was resolved, in accordance with anti-doping rules.

"Athletes are prohibited from competing, practicing, becoming coaches, or participating in any activities during the 2024 Paris Olympics," they said.

"The athlete has the right to object to suspension at the Court of Arbitration for Sport - Anti-Doping Division," they continued. Sehen also has the right to request analysis of sample B.